Literature DB >> 8450937

31P magnetic resonance spectroscopy in Alzheimer's and Pick's disease.

C D Smith1, L G Gallenstein, W J Layton, R J Kryscio, W R Markesbery.   

Abstract

Previous studies have suggested a defect in phosphorus metabolism in Alzheimer's disease (AD) gray matter. We have studied phosphorus metabolites in both gray and white matter in autopsy specimens of nine subjects with late-stage AD, three with Pick's disease and seven age-matched controls. Phosphorus metabolites sugar phosphate (SU), phosphomonoester (PME), phosphodiester (PD), and inorganic phosphate (PI) were quantified as mole percentages in regional neocortical specimens using nuclear magnetic resonance spectroscopy. Senile plaque (SP) and neurofibrillary tangle (NFT) counts were determined in adjacent cortical sections. In the inferior parietal lobule gray and white matter, mole percentage normalized PME, and PD were significantly greater than control values in both AD and Pick's disease. A significant correlation was found between PD and NFT in AD parietal gray matter. Our data indicates that phosphorus metabolite alterations are present in two cortical degenerative diseases and are not likely to be specific for AD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450937     DOI: 10.1016/0197-4580(93)90026-8

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  11 in total

1.  Regional membrane phospholipid alterations in Alzheimer's disease.

Authors:  M R Prasad; M A Lovell; M Yatin; H Dhillon; W R Markesbery
Journal:  Neurochem Res       Date:  1998-01       Impact factor: 3.996

Review 2.  Magnetic resonance imaging and magnetic resonance spectroscopy in dementias.

Authors:  Y Y Hsu; A T Du; N Schuff; M W Weiner
Journal:  J Geriatr Psychiatry Neurol       Date:  2001       Impact factor: 2.680

3.  Brain membrane phospholipid alterations in Alzheimer's disease.

Authors:  J W Pettegrew; K Panchalingam; R L Hamilton; R J McClure
Journal:  Neurochem Res       Date:  2001-07       Impact factor: 3.996

4.  Interactions of Abeta(1-40) with glycerophosphocholine and intact erythrocyte membranes: fluorescence and circular dichroism studies.

Authors:  Pravat K Mandal; Richard J McClure; Jay W Pettegrew
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

Review 5.  The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease.

Authors:  O V Forlenza; E L Schaeffer; W F Gattaz
Journal:  J Neural Transm (Vienna)       Date:  2006-11-27       Impact factor: 3.575

6.  Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study.

Authors:  Orestes V Forlenza; Priscilla Wacker; Paula V Nunes; Juliana Yacubian; Claudio C Castro; Maria C G Otaduy; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2005-02-08       Impact factor: 4.530

Review 7.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

8.  Proton chemical shift imaging in pick complex.

Authors:  Osamu Kizu; Kei Yamada; Tsunehiko Nishimura
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

Review 9.  What might be the impact on neurology of the analysis of brain metabolism by in vivo magnetic resonance spectroscopy?

Authors:  J Vion-Dury; D J Meyerhoff; P J Cozzone; M W Weiner
Journal:  J Neurol       Date:  1994-05       Impact factor: 4.849

Review 10.  Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme.

Authors:  Evelin L Schaeffer; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.